Caryn G. McDowell
Overview
Caryn G. McDowell received an average of $2M in total compensation, including $338K in salary, at Revance Therapeutics between 2018 and 2019.
Source: SEC filings on March 26, 2020 and March 25, 2019.
Related executives
We found 12 more executives who work or worked at Revance Therapeutics.
Mark Foley
Revance Therapeutics
Chief Executive Officer
Dustin Sjuts
Revance Therapeutics
President
Aubrey Rankin
Revance Therapeutics
Former President, Innovation & Technology
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
Dwight Moxie
Revance Therapeutics
General Counsel
L Browne
Revance Therapeutics
Chief Executive Officer
Todd Zavodnick
Revance Therapeutics